Skip to main content
HairCited

Ferro per Telogen effluvium

B

Basato su 56 studi (2 RCTs) con 11,067 partecipanti totali. I risultati sono contrastanti tra gli studi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Iron may support recovery from telogen effluvium, particularly when low ferritin levels are confirmed, but the evidence is mixed and routine supplementation without testing is not well-supported.

  • 56 studies provide substantial evidence, though results are mixed across the research
  • Lower ferritin levels are commonly found in patients with telogen effluvium
  • One study found iron supplementation improved satisfaction even in patients without overtly low ferritin
  • Blood testing for ferritin and iron levels is recommended before starting supplementation

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: women with androgenetic alopecia (female pattern hair loss)

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Effetto: None None
Retrospective cohort n=2851
Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.
Dose: None vs: Placebo Effetto: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Effetto: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None

Key Statistics

62

Studi

11072

Partecipanti

Mixed

B

Grado

Referenced Papers

Journal of drugs … 2021 3 citazioni
Acta dermatovenerologica Croatica … 2016 6 citazioni
Journal of clinical … 2015 190 citazioni
The Medical clinics … 2015 66 citazioni
Clinical obstetrics and … 2015 9 citazioni
Turkish journal of … 2014 5 citazioni
Annals of gastroenterology 2014 5 citazioni
Skin pharmacology and … 2013 127 citazioni
Seminars in cutaneous … 2006 23 citazioni
American journal of … 2005 140 citazioni
Journal of the … 2005 64 citazioni
Revue medicale de … 2004
The Journal of … 2003 222 citazioni
International journal of … 2002 95 citazioni
Dermatologic clinics 1993 38 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
18 mg/day (women)
deficiency:
65-200 mg elemental iron/day

Limite massimo: 45 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Mixed --
None -- Neutral 2851
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Positive --
not applicable (observational; serum ferritin measured) -- Negative 100
None -- Mixed --

Momento migliore per l'assunzione: On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

Effetti collaterali segnalati

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

Interazioni note

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

Livello di assunzione massimo tollerabile: 45 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Ferro help with Telogen effluvium?
Based on 62 studies with 11,072 participants, there is moderate evidence from clinical studies that Ferro may support Telogen effluvium management. Our evidence grade is B (Good Evidence).
How much Ferro should I take for Telogen effluvium?
Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ferro?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ferro and Telogen effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 62 peer-reviewed studies with 11,072 total participants. The overall direction of effect is mixed.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.